MACH7 TECHNOLOGIES LIMITED — Board/Management Information 2026

May 3, 2026

MACH7 ASX Announcement

4 May 2026

CFO TRANSITION

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a healthcare software company that enables health systems to securely store, access and share diagnostic images across disparate systems, advises that its Chief Financial Officer (CFO) Daniel Lee has resigned from his position to focus on family priorities. Shawni Hadfield, Mach7’s Vice President, Commercial Excellence, has been appointed Interim CFO, effective immediately. Mr Lee will remain with Mach7 for a period of time to support an orderly transition.

Shawni Hadfield is a senior finance leader with prior CFO experience and deep expertise in SaaS financial management, capital markets, and business operations. She has a proven track record scaling and professionalising high-growth SaaS businesses, driving Annual Recurring Revenue (ARR) growth, improving profitability, and building finance and operational capability in lean environments. Ms Hadfield’s appointment as Interim CFO creates a strong link between the sales, support and finance functions, guaranteeing continuity and disciplined execution across the Company’s financial and operational functions.

The Board would like to thank Mr Lee for his contribution and wishes him well in his future endeavours.

Released on authority of the Board by Teri Thomas, Managing Director and Chief Executive Officer.

For more information, contact:

Investor Relations
Françoise Debelak
+61 (0) 412 292 977
ir@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) provides enterprise imaging software that enables healthcare organisations to manage, access and share diagnostic imaging data across complex environments. The Mach7 platform combines a Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer and the Flamingo suite of modules, expanding capabilities across workflow, interoperability and data management to support a more complete view of the patient record. Together, these capabilities position Mach7 to support the evolution of enterprise imaging toward a more unified, longitudinal patient record that integrates clinical data and diagnostic imaging. Built for interoperability and scalability, Mach7 supports emerging AI-driven clinical workflows and is increasingly aligned with leading cloud ecosystems, including Amazon Web Services (AWS). The Company serves a global customer base including integrated delivery networks, national health systems and specialist imaging providers. Visit mach7t.com for more information.

---

MACH7 ASX Announcement

Forward-looking statements

This announcement may contain forward-looking statements regarding the Company's financial position, business strategy and objectives (rather than being based on historical or current facts). Any forward-looking statements are based on the current beliefs of the Company's management as well as assumptions made by, and information currently available to, the Company's management. Forward-looking statements are inherently uncertain and must be read accordingly. There can be no assurance that some or all of the underlying assumptions will prove to be valid.

All data presented in this announcement reflects the current views of the Company with respect to future events. Forward-looking statements are subject to risk, uncertainties and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Company. To the maximum extent permitted by law, the Company, its officers, employees and agents do not accept any obligation to release any updates or revisions to the information (including any forward-looking statements) in this announcement to reflect any change to expectations or assumptions; and disclaim all responsibility and liability for any loss arising from reliance on this announcement or its contents.

Independence through Innovation

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192
Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000
T: +61 1300 384 692
www.mach7t.com